| Code | 35917 | ||||||||||
| MA number | EU/1/06/347/003 | ||||||||||
| Product Form: | cps dur 30x50 mg (fľ. HDPE) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 19.07.2006 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC SUTENT II-27_SK_FINAL_20Jan11_appr-SIDC (Gibala).pdf
|
| Safety feature | Yes |
| Data update: | 11.10.2021 |
